Nav: Home

La Jolla Institute for Allergy and Immunology team receives $18 million consortium grant

December 17, 2015

LA JOLLA, CA - The La Jolla Institute for Allergy and Immunology (LJI) is pleased to announce that an international team led by LJI investigator Alessandro Sette, Ph.D., is one of four recipients of a Human Immune Profiling Consortium (HIPC) grant in 2015. With this prestigious grant, the LJI team will characterize the immune response to dengue virus (DENV) and Mycobacterium tuberculosis (TB), both of which represent major global health challenges.

"Advances in technology and data analysis have given us sophisticated tools to study the activity of the human immune system across diverse populations in unprecedented depth," said Mitchell Kronenberg, Ph.D., President and Chief Scientific Officer. "The HIPC grant award is a testament to the caliber of our scientists and validates our sustained efforts to facilitate vaccine development. But most importantly, it provides us with the opportunity to unleash the full force of our collective scientific expertise and technological capabilities to trace what are the elements that make up an effective immune response."

The HIPC award presented to LJI will support both research and the collection, shipping, and processing of thousands of samples from a network of clinical sites around the world (Sri Lanka, Nicaragua, Peru, and Sweden). Employing samples from such a geographically and ethnically diverse populations will ensure that conclusions drawn from this research are broadly applicable.

The consortium will apply unbiased methods to identify groups of genes expressed in T cells, and key white blood cell type, associated with protection from or susceptibility to the two diseases. These group of genes that determines function are sometimes referred to as gene signatures. This open-ended approach relies heavily on RNA sequencing, a cutting-edge technique to identify genes whose expression is enhanced or diminished by a particular condition. RNA sequencing studies will be overseen by Pandurangan Vijayanand, Ph.D., an expert in immunological genomics, and the vast amounts of data generated will be interpreted by a bioinformatics team led by Bjoern Peters, Ph.D. The research will also benefit from the expertise of lead scientists Daniela Weiskopf, Ph.D. and Cecilia Lindestam Arlehamn, Ph.D., who have each made several important contributions to the understanding of T cells in DENV and M. tuberculosis infection, respectively.

"By comparing and contrasting the gene expression signatures associated with disease and protection from disease, we will better understand what kind of immune responses vaccines should induce in order to be protective," said Bjoern Peters, Ph.D., an associate professor in the Division of Vaccine Discovery, who is spearheading the tuberculosis project in addition to performing the bioinformatics analysis for both pathogens.

As T cells contribute to immunity and pathology in dengue and TB, this profiling effort is likely to identify new factors that affect the risk of developing severe disease from these pathogens, which could lead to new indicators of effective vaccines. Development of vaccines for both diseases is urgent. Dengue prevalence is increasing as its mosquito vectors spread over greater areas and antibiotic-resistant TB strains are becoming more common. No vaccine against DENV has yet been approved, and the available TB vaccine provides only variable protection against pulmonary disease in adults.

In addition to direct implications for vaccine development, HIPC-supported research at LJI also addresses the fundamental question of whether infection with and vaccination against DENV or TB induce qualitative or quantitative changes in T cell populations. In other words, whether pathogen-specific T cells are an expanded population of previously existing cells, or if this expansion also involves a change that generates new T cell properties. The planned studies can help resolve this issue because of their scale and their use of whole-genome approaches, capturing all differences between healthy controls, previously infected, actively infected, and vaccinated populations. Further, comparing patterns across the two diseases will allow conclusions about T cell responses to viral pathogens in general, which would have fundamental impact on the understanding of human immunology.

The HIPC program was established by the National Institutes of Allergy and Infectious Disease to support the study of human immunology using modern analytic tools and computational methods. The overall goal is to provide a comprehensive understanding of the human immune system and its regulation, providing a foundation for the future study of immune-mediated diseases. Information gathered in the course of HIPC research is openly shared with the research community via the ImmPort database.

La Jolla Institute for Allergy and Immunology is dedicated to understanding the intricacies and power of the immune system so that we may apply that knowledge to promote human health and prevent a wide range of diseases. Since its founding in 1988 as an independent, nonprofit research organization, the Institute has made numerous advances leading towards its goal: life without disease®.

La Jolla Institute for Allergy and Immunology

Related Immune Response Articles:

Discovering the early age immune response in foals
Researchers at the Cornell University College of Veterinary Medicine have discovered a new method to measure tiny amounts of antibodies in foals, a finding described in the May 16 issue of PLOS ONE.
Nixing the cells that nix immune response against cancer
For first time, study characterizes uptick of myeloid-derived suppressor cells in the spleens of human cancer patients, paving the way for therapies directed against these cells that collude with cancer.
Jumbled chromosomes may dampen the immune response to tumors
How well a tumor responds to immunotherapy may depend in part on whether its chromosomes are intact or in a state of disarray, a new study reports.
Tailored organoid may help unravel immune response mystery
Cornell and Weill Cornell Medicine researchers report on the use of biomaterials-based organoids in an attempt to reproduce immune-system events and gain a better understanding of B cells.
Tweaking the immune response might be a key to combat neurodegeneration
Patients with Alzheimer's or other neurodegenerative diseases progressively loose neurons yet cannot build new ones.
Estrogen signaling impacted immune response in cancer
New research from The Wistar Institute showed that estrogen signaling was responsible for immunosuppressive effects in the tumor microenvironment across cancer types.
No platelets, no immune response
When a virus attacks our organism, an inflammation appears on the affected area.
Malaria: A genetically attenuated parasite induces an immune response
With nearly 3.2 billion people currently at risk of contracting malaria, scientists from the Institut Pasteur, the CNRS and Inserm have experimentally developed a live, genetically attenuated vaccine for Plasmodium, the parasite responsible for the disease.
New finding will help target MS immune response
Researchers have made another important step in the progress towards being able to block the development of multiple sclerosis and other autoimmune diseases.
Flu infection reveals many paths to immune response
A new study of influenza infection in an animal model broadens understanding of how the immune system responds to flu virus, showing that the process is more dynamic than usually described, engaging a broader array of biological pathways.

Related Immune Response Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Changing The World
What does it take to change the world for the better? This hour, TED speakers explore ideas on activism—what motivates it, why it matters, and how each of us can make a difference. Guests include civil rights activist Ruby Sales, labor leader and civil rights activist Dolores Huerta, author Jeremy Heimans, "craftivist" Sarah Corbett, and designer and futurist Angela Oguntala.
Now Playing: Science for the People

#521 The Curious Life of Krill
Krill may be one of the most abundant forms of life on our planet... but it turns out we don't know that much about them. For a create that underpins a massive ocean ecosystem and lives in our oceans in massive numbers, they're surprisingly difficult to study. We sit down and shine some light on these underappreciated crustaceans with Stephen Nicol, Adjunct Professor at the University of Tasmania, Scientific Advisor to the Association of Responsible Krill Harvesting Companies, and author of the book "The Curious Life of Krill: A Conservation Story from the Bottom of the World".